Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk
María J. Forteza(Karolinska University Hospital), Daniel F.J. Ketelhuth(Karolinska University Hospital), Thue W. Schwartz(University of Copenhagen), Konstantinos A. Polyzos(Karolinska University Hospital), Lea Dib(Nuffield Orthopaedic Centre), Ljubica Matic(Karolinska University Hospital), Petras P. Dzeja(Mayo Clinic), Ilona Kareinen(Karolinska University Hospital), Jiangming Sun(Malmö University), Isabel Gonçalves(Lund University), Mette Trauelsen(University of Copenhagen), M Berg(Karolinska University Hospital), Ulf Hedin(Karolinska Institutet), Felipe Beccaria Casagrande(Karolinska University Hospital), Ivan Vučković(Mayo Clinic), Claudia Monaco(Nuffield Orthopaedic Centre), Anton Gisterå(Karolinska University Hospital), Song Zhang(Mayo Clinic), Roland Baumgartner(Karolinska University Hospital), Joerg Herrmann(Mayo Clinic), Andreas Edsfeldt(Lund University)
Cited by 74
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
Editor's Choice – Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)
|European Journal of Vascular and Endovascular Surgery|2018|829
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589